| Financial Year |
March 31 2023 |
| Monetary Funds |
93,668,666.99 |
| Held-for-trading Financial Assets |
66,592,683.11 |
| Notes Receivable |
75,903,615.77 |
| Accounts Receivable |
208,870,113.04 |
| Advances to Suppliers |
12,317,895.22 |
| Other Receivables |
4,333,867.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
93,619,022.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,360,697.98 |
| Total Current Assets |
579,997,576.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
172,787,693.76 |
| Under-construction Projects |
142,103,469.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
80,605,452.91 |
| R&D expenses |
-- |
| Goodwill |
79,684,870.86 |
| Long-Term Deferred and Prepaid Expenses |
11,687,118.67 |
| Deferred Income Tax Assets |
32,273,846.77 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
522,036,766.94 |
| Total Assets |
1,102,034,343.80 |
| Short-Term Loans |
134,390,519.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
26,728,627.00 |
| Accounts Payable |
104,235,929.17 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,608,690.10 |
| Taxes Payable |
11,583,267.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,251,075.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,348,096.30 |
| Other Current Liabilities |
67,268,520.80 |
| Sub-Total of Current Liabilities |
364,477,111.05 |
| Long-term Loans |
49,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,029,962.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
66,266,799.71 |
| Total Liabilities |
430,743,910.76 |
| Paid-In Capital(Or Share Stock) |
193,027,584.00 |
| Capital Surplus |
835,393,421.25 |
| Surplus Reserve |
31,589,162.51 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-387,351,495.31 |
| Minority Stockholder's Interest |
-1,368,239.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
672,658,672.45 |
| Owner's Equity（Stockholder's Equity） |
671,290,433.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,102,034,343.80 |
